Fibromyalgia, Primary Clinical Trial
Official title:
Efficacy of Perineural Injection Therapy in a Group of Egyptians Patients With Primary Fibromyalgia: Non-Randomized Controlled Study
The goal of fibromyalgia Treatment is to relieve the pain and improve quality of life and physical function which need a Final Version: April 2019Research Template 3 multifaceted treatment approach involving non pharmacological pain management and medicine Lyftgot perineural injection therapy "lyftgot PIT" previously known as neural prolotherapy , is a method of injection treatment designed and developed by DR Lyftgot from new Zealand to treat the neurogenic inflammation and the neuropathic pain caused by the sensocrine small nerve fiber .PIT is based on the injection of small amount of dextrose 5%in a neutral PH sterile water solution in the subcutaneous tissue around the sick nerve to correct the neuroglycopenia and to inhibit the neurogenic inflammation.
Fibromyalgia is a chronic non inflammatory wide spread pain disorder associated with a complex of symptoms as fatigue, depression and cognitive impairment , it is the second most common disorder encountered in rheumatology practice (Berger et aL,2007) The pathophysiology is certainly unclear involves a number of factors , including abnormalities in the neuroendocrine and autonomic nervous system ,psychological variables, genetic factor, and environmental stressors (Hudson JI, 2006 ) Fibromyalgia is no longer a diagnosis of exculsion ,patient are diagnosed according to the American college of rheumatology diagnostic criteria which requires a three conditions to be met a wide spread pain index >7 and symptom severity scale score >5 or WPI from 3-6 and ss scale score >9, symptoms have been present at similar level for at least 3 month and patient doesn't have a disorderthat would otherwise explain the pain The goal of fibromyalgia Treatment is to relieve the pain and improve quality of life and physical function which need a Final Version: April 2019Research Template 3 multifaceted treatment approach involving non pharmacological pain management and medicine Lyftgot perineural injection therapy "lyftgot PIT" previously known as neural prolotherapy , is a method of injection treatment designed and developed by DR Lyftgot from new Zealand to treat the neurogenic inflammation and the neuropathic pain caused by the sensocrine small nerve fiber .PIT is based on the injection of small amount of dextrose 5%in a neutral PH sterile water solution in the subcutaneous tissue around the sick nerve to correct the neuroglycopenia and to inhibit the neurogenic inflammation These small nerve fibers are responsible for delivering to the tissue the nerve growth factors necessary for the repair healing and reconstruction of the connective tissue system connecting the superficial skin system to the deep myo-fascial-skeletal system and for restoration of its original compostion with its normal osmotic and electro magnetic pressure (lyftogt,2007) Dextrose 5% block the TRPV1 receptor which inhibit the propagation of the neuropathic pain signal giving the patient the immediate analgesia , it also inhibit the neurogenic inflammation and stimulate the release of nerve growth factor that help in thr repair PIT is a novel , safe, effective and economical treatment for the pain felt in fibromyalgia In this study we aim to asses the efficacy of this treatment in alleviating the pains felt by these patients ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03149198 -
Mat Pilates Method in the Treatment of Women With Fibromyalgia
|
N/A | |
Completed |
NCT00965081 -
A Study for Adult Patients With Fibromyalgia
|
Phase 4 | |
Enrolling by invitation |
NCT06100926 -
Effectiveness of Virtual Reality (VR) in Non-oncologic Chronic Musculoskeletal Pain
|
N/A | |
Recruiting |
NCT05068791 -
Psilocybin-facilitated Treatment for Chronic Pain
|
Early Phase 1 | |
Recruiting |
NCT05801497 -
Balneotherapy in Primary Fibromyalgia
|
||
Active, not recruiting |
NCT04422522 -
Fibromyalgia During the COVID-19 Pandemic
|
||
Completed |
NCT05361577 -
Exopulse Mollii Suit and Fibromyalgia
|
N/A | |
Recruiting |
NCT05754190 -
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
|
||
Recruiting |
NCT05941780 -
Pain Phenotypes in Patients With Fibromyalgia Syndrome
|
||
Not yet recruiting |
NCT06424743 -
Preference of Women With Fibromyalgia Undergoing a Three Different Volumes of Resistance Training
|
N/A | |
Completed |
NCT04771260 -
Understanding Health Services Delivery for Fibromyalgia
|
||
Active, not recruiting |
NCT04690400 -
Telehealth Stretching Exercise Program for Women With Fibromyalgia During the Covid-19 Pandemic
|
N/A | |
Recruiting |
NCT05644054 -
The Impact of THC on Pain Modulation in Fibromyalgia
|
N/A | |
Enrolling by invitation |
NCT04098757 -
Fibromyalgia Different Approaches: Acupuncture vs Migratens
|
||
Completed |
NCT01697254 -
The CARRA Registry
|
N/A | |
Completed |
NCT00678691 -
An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue
|
Phase 4 | |
Recruiting |
NCT04832100 -
Bio-significance of LPC16:0 in Fibromyalgia
|
||
Completed |
NCT03905486 -
Efficacy of Pregabalin Versus Combined Pregabalin and Milnacipran in Fibromyalgia.
|
N/A |